These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6933888)

  • 1. Marked hypophosphatemia associated with acute myelomonocytic leukemia. Indirect evidence of phosphorus uptake by leukemic cells.
    Zamkoff KW; Kirshner JJ
    Arch Intern Med; 1980 Nov; 140(11):1523-4. PubMed ID: 6933888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute myeloid leukemia possibly producing thrombopoietic factor(s).
    Fujita A; Matsuoka M; Shimonaka Y; Imai N; Asano S
    Jpn J Clin Oncol; 1993 Dec; 23(6):366-72. PubMed ID: 7506802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A 45-year-old man with peripheral monocytosis and right hemiparesis].
    Takubo H; Hattori N; Irie S; Mizutani Y; Mori H; Suda K; Kondo T; Oshimi K; Mizuno Y
    No To Shinkei; 1998 May; 50(5):481-9. PubMed ID: 9621375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypophosphatemia in a patient with lymphoma in leukemic phase.
    Matzner Y; Prococimer M; Polliack A; Rubinger D; Popovtzer MM
    Arch Intern Med; 1981 May; 141(6):805-6. PubMed ID: 7016060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chronic myelomonocytic leukemia].
    Iavorkovskiĭ LI; Soloveĭ DIa; Press BO; Rudens IuF; Reĭskart LV
    Probl Gematol Pereliv Krovi; 1974 Jan; 19(1):40-5. PubMed ID: 4534126
    [No Abstract]   [Full Text] [Related]  

  • 6. [Transient hypophosphatemia associated with hairy-cell leukemia].
    Bar-Khayim Y; Haran N; Gurwicz S; Bereby A; Popovtzer M
    Harefuah; 1990 Jan; 118(2):83-4. PubMed ID: 2312008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 overexpression in myeloid leukemic disorders is associated with increased apoptosis of hematopoietic marrow cells and ineffective hematopoiesis.
    Orazi A; Kahsai M; John K; Neiman RS
    Mod Pathol; 1996 Jan; 9(1):48-52. PubMed ID: 8821956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe hypophosphatemia in hospitalized patients.
    Halevy J; Bulvik S
    Arch Intern Med; 1988 Jan; 148(1):153-5. PubMed ID: 3122679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythrophagocytosis by dysplastic neutrophils in chronic myelomonocytic leukemia and subsequent transformation to acute myeloid leukemia.
    Etzell J; Lu CM; Browne LW; Wang E
    Am J Hematol; 2005 Aug; 79(4):340-2. PubMed ID: 16044446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of intravenous phosphorus therapy in the severely hypophosphatemic patient.
    Vannatta JB; Whang R; Papper S
    Arch Intern Med; 1981 Jun; 141(7):885-7. PubMed ID: 7235807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute transformation of chronic myelomonocytic leukemia with t(1;3) (p36;q21) abnormality].
    Onishi Y; Nakamichi T; Maeda Y; Chinzei T; Nakagawa T; Saigo K
    Rinsho Ketsueki; 1998 Jul; 39(7):519-25. PubMed ID: 9750460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of in vivo administration of interleukin 3 on proliferation, differentiation, and chemosensitivity of acute myeloid leukemia.
    Gore SD; Weng LJ; Jones RJ; Cowan K; Zilcha M; Piantadosi S; Burke PJ
    Clin Cancer Res; 1995 Mar; 1(3):295-303. PubMed ID: 9815985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of indirect determination of leukemic infiltration of the liver based on clinical findings and findings in the bone marrow and peripheral blood in patients with chronic leukemia].
    Todorović M; Crepinko I; Dominis M
    Lijec Vjesn; 1984; 106(11-12):452-5. PubMed ID: 6596475
    [No Abstract]   [Full Text] [Related]  

  • 14. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of hypophosphatemia using a protocol based on patient weight and serum phosphorus level in a surgical intensive care unit.
    Taylor BE; Huey WY; Buchman TG; Boyle WA; Coopersmith CM
    J Am Coll Surg; 2004 Feb; 198(2):198-204. PubMed ID: 14759775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular IL-4, IL-10, and IFN-gamma levels of leukemic cells and bone marrow T cells in acute leukemia.
    Park HH; Kim M; Lee BH; Lim J; Kim Y; Lee EJ; Min WS; Kang CS; Kim WI; Shim SI; Han K
    Ann Clin Lab Sci; 2006; 36(1):7-15. PubMed ID: 16501231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chronic myelomonocytic leukemia. Analysis of 21 cases].
    Ribera JM; Cervantes F; Olivé MT; Rozman C
    Med Clin (Barc); 1985 Mar; 84(9):344-8. PubMed ID: 3857423
    [No Abstract]   [Full Text] [Related]  

  • 18. Concurrent acute myeloid leukemia with inv(16)(p13.1q22) and chronic lymphocytic leukemia: molecular evidence of two separate diseases.
    Lu CM; Murata-Collins JL; Wang E; Siddiqi I; Lawrence H
    Am J Hematol; 2006 Dec; 81(12):963-8. PubMed ID: 16917916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recognition of clonogenic leukemic cells, remission bone marrow and HLA-identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific cytotoxic T lymphocytes.
    Faber LM; van der Hoeven J; Goulmy E; Hooftman-den Otter AL; van Luxemburg-Heijs SA; Willemze R; Falkenburg JH
    J Clin Invest; 1995 Aug; 96(2):877-83. PubMed ID: 7635982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Low-dose cytarabine ocfosfate therapy in an elderly acute myelogenous leukemia].
    Hamaoka R; Jozaki K; Amano T; Itoh H; Imai Y; Nishikawa M; Kurokawa M; Yonezawa T; Chinen Y
    Gan To Kagaku Ryoho; 1995 May; 22(6):819-22. PubMed ID: 7755392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.